Skip to content

McKesson MCK Accounts Payable

Accounts Payable at other companies

Eli Lilly logo
Eli LillyLLY
$5.03B+46.1%
Cardinal Health logo
Cardinal HealthCAH
$37.83B+15.3%
Cencora logo
CencoraCOR
$51.88B+3.5%
Viatris logo
ViatrisVTRS
$1.75B-12.0%
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
$47.65M+62.7%
Medline, Inc.
 logo
Medline, Inc. MDLN
$932M+2,563%

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$104.14B+17.1%
Enterprise value$102.44B+5.1%
P/E21.9×-6.2×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's accounts payable?
McKesson (MCK) reported accounts payable of $59.97B in Q1 2026.
How has McKesson's accounts payable changed year-over-year?
McKesson's accounts payable increased by 8.4% year-over-year, from $55.33B to $59.97B.
What is the long-term trend for McKesson's accounts payable?
Over 5 years (2021 to 2026), McKesson's accounts payable has grown at a 9.0% compound annual growth rate (CAGR), from $38.98B to $59.97B.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.